Research
Hormonal
Liraglutide and semaglutide may provide benefits for weight loss and glycaemic control in people living with HIV.
Practitioners may consider liraglutide and semaglutide for weight management in HIV patients, particularly those with diabetes.
StrongSupportsmedium confidence
Clinical experience is limited to two clinical cases of diabetic people with HIV using liraglutide after which a successful weight loss and glycaemic control were observed.
Why this rating
Based on clinical observations mentioned in the abstract.
Source
<scp>GLP</scp>‐1 agonists for people living with <scp>HIV</scp> and obesity, is there a potential?
Leena Zino et al. · HIV Medicine · 2023
case_studyCited 8×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →